Summary
The mission of the Michigan Cancer Research Consortium (MCRC) is to improve cancer care in the communities it serves, through access to NCI trials. First funded in 1994, as a single hospital Community Clinical Oncology Program, MCRC is now comprised of 15 hospitals and many investigators from 47 practices in five states. MCRC’s membership is a mix of health systems characterized by one or more features critical to performing cancer clinical trials work: Most MCRC members collaborate with Academic Medical Centers. This means they have capabilities for challenging treatment trials and retain pat
